Last reviewed · How we verify
NCT03821155
Does Vestibular Rehabilitation Significantly Improve the Level of Vestibular Function Following Vestibular Neuritis?
NA trial testing Vestibular rehabilitation in Vestibular Neuritis in 50 participants. Completed in 1 January 2022.
1 July 2021
Quick facts
| Lead sponsor | Aalborg University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 February 2019 |
| Primary completion | 1 July 2021 |
| Estimated completion | 1 January 2022 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Vestibular rehabilitation
- Corticosteroid — full drug profile →
Conditions studied
- Vestibular Neuritis — all drugs for Vestibular Neuritis →
Sponsor
Aalborg University Hospital
Who can join
18 and older, any sex, with Vestibular Neuritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To investigate which treatment option (corticosteroid treatment alone or combined corticosteroid treatment and vestibular rehabilitation) is the most effective in patients diagnosed with vestibular neuritis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03821155
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vestibular rehabilitation
Trials testing the same drug.
- NCT03431506 — Vestibular Function and Vestibular Rehabilitation in SSHL With Vertigo · NA · unknown
Other recruiting trials for Vestibular Neuritis
Currently open trials in the same condition.
- NCT04678167 — Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis · NA · recruiting
Other Aalborg University Hospital trials
Trials by the same sponsor.
- NCT06960005 — ThyMoves: Screening and Exercise to Improve Muscle, Enhance Quality of Life, and Reduce Fall Risk in Thyroid Disease · NA · enrolling by invitation
- NCT06745544 — Impact of Screening and Multicomponent Exercise on Fall Rates, Fractures, and Cardiovascular Health in Diabetes · NA · recruiting
- NCT07185958 — Dual Energy CT - a Tool for Delineation of Tumor and Organs at Risk in Radiotherapy · not yet recruiting
- NCT07165574 — Prevalence of Anticholinergics in Geriatric Patients With Acute Functional Deterioration · not yet recruiting
- NCT07173413 — Assessing the Quality of Telephone Follow-Up After Spine Surgery · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03821155 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aalborg University Hospital
- Last refreshed: 29 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03821155.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing